☆ 4.6 Letter

Positron emission tomography response and minimal residual disease impact on progression-free survival in patients with follicular lymphoma. A subset analysis from the FOLL05 trial of the Fondazione Italiana Linfomi

HAEMATOLOGICA (2016)

Get Full Text
Add to Collection

Journal

HAEMATOLOGICA
Volume 101, Issue 2, Pages E66-E68

Publisher

FERRATA STORTI FOUNDATION
DOI: 10.3324/haematol.2015.132811

Keywords

follicular lymphoma; minimal residual disease; nuclear medicine; FDG-PET; progression-free survival

Categories

Hematology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.